Cargando…

Type 2 Diabetes as a Determinant of Parkinson’s Disease Risk and Progression

BACKGROUND: Type 2 diabetes (T2DM) and Parkinson’s disease (PD) are prevalent diseases that affect an aging population. Previous systematic reviews and meta-analyses have explored the relationship between diabetes and the risk of PD, but the results have been conflicting. OBJECTIVE: The objective wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chohan, Harneek, Senkevich, Konstantin, Patel, Radhika K., Bestwick, Jonathan P., Jacobs, Benjamin M., Ciga, Sara Bandres, Gan-Or, Ziv, Noyce, Alastair J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017318/ https://www.ncbi.nlm.nih.gov/pubmed/33682937 http://dx.doi.org/10.1002/mds.28551

Ejemplares similares

Parkinson’s disease determinants, prediction and gene–environment interactions in the UK Biobank
por: Jacobs, Benjamin Meir, et al.
Publicado: (2020)

Lower Lymphocyte Count is Associated With Increased Risk of Parkinson’s Disease
por: Jensen, Melanie P., et al.
Publicado: (2021)

Bidirectional relationship between olfaction and Parkinson’s disease
por: Kim, Jonggeol J., et al.
Publicado: (2023)

Genome-wide association study stratified by MAPT haplotypes identifies potential novel loci in Parkinson’s disease
por: Senkevich, Konstantin, et al.
Publicado: (2023)

Evaluating Lipid‐Lowering Drug Targets for Parkinson's Disease Prevention with Mendelian Randomization
por: Williams, Dylan M., et al.
Publicado: (2020)

Effect Modification between Genes and Environment and Parkinson's Disease Risk
por: Periñán, Maria Teresa, et al.
Publicado: (2022)

Tumor Necrosis Factor Inhibition and Parkinson Disease: A Mendelian Randomization Study
por: Kang, Xiaoying, et al.
Publicado: (2021)

Black and African American Connections to Parkinson's Disease Study: Addressing Missing Diversity in Parkinson's Disease Genetics
por: Bandres‐Ciga, Sara
Publicado: (2022)

Immunogenetic Determinants of Parkinson’s Disease Etiology
por: Kung, Pin-Jui, et al.
Publicado: (2022)

Polygenic Resilience Modulates the Penetrance of Parkinson Disease Genetic Risk Factors
por: Liu, Hui, et al.
Publicado: (2022)

Unhealthy Behaviours and Risk of Parkinson’s Disease: A Mendelian Randomisation Study
por: Heilbron, Karl, et al.
Publicado: (2021)

Heritability Enrichment Implicates Microglia in Parkinson’s Disease Pathogenesis
por: Andersen, Maren Stolp, et al.
Publicado: (2021)

The Genetic Landscape of Parkinsonism-Related Dystonias and Atypical Parkinsonism-Related Syndromes
por: Diez-Fairen, Monica, et al.
Publicado: (2021)

Gene-Environment Interactions in Multiple Sclerosis: A UK Biobank Study
por: Jacobs, Benjamin Meir, et al.
Publicado: (2021)

Genetics of NLRP3 suggests lack of involvement and inefficient druggability in Parkinson’s disease
por: Senkevich, Konstantin, et al.
Publicado: (2023)

Gender Differences in the Prevalence of Parkinson's Disease
por: Zirra, Alexandra, et al.
Publicado: (2022)

Bone health in Parkinson's disease: a systematic review and meta-analysis
por: Torsney, Kelli M, et al.
Publicado: (2014)

Exploring the genetic and genomic connection underlying neurodegeneration with brain iron accumulation and the risk for Parkinson’s disease
por: Alvarez Jerez, Pilar, et al.
Publicado: (2023)

The Parkinson's Disease Mendelian Randomization Research Portal
por: Noyce, Alastair J., et al.
Publicado: (2019)

Mapping the Diverse and Inclusive Future of Parkinson’s Disease Genetics and Its Widespread Impact
por: Elsayed, Inas, et al.
Publicado: (2021)

Advancing Personalized Medicine in Common Forms of Parkinson’s Disease through Genetics: Current Therapeutics and the Future of Individualized Management
por: Reed, Xylena, et al.
Publicado: (2021)

Identification and prediction of Parkinson’s disease subtypes and progression using machine learning in two cohorts
por: Dadu, Anant, et al.
Publicado: (2022)

Meta-Analysis of Early Nonmotor Features and Risk Factors for Parkinson Disease
por: Noyce, Alastair J, et al.
Publicado: (2012)

A population scale analysis of rare SNCA variation in the UK Biobank
por: Blauwendraat, Cornelis, et al.
Publicado: (2020)

RIC3 variants are not associated with Parkinson’s disease in large European, Latin American, or East Asian cohorts
por: Brolin, Kajsa, et al.
Publicado: (2022)

MIDN locus structural variants and Parkinson's Disease risk
por: Billingsley, Kimberley J., et al.
Publicado: (2020)

Unraveling the genetic complexity of Alzheimer disease with Mendelian Randomization
por: Bandres-Ciga, Sara, et al.
Publicado: (2019)

Genetic Risk Profiling in Parkinson’s Disease and Utilizing Genetics to Gain Insight into Disease-Related Biological Pathways
por: Hall, Ashley, et al.
Publicado: (2020)

Analysis of rare Parkinson’s disease variants in millions of people
por: Pitz, Vanessa, et al.
Publicado: (2023)

Optimising classification of Parkinson’s disease based on motor, olfactory, neuropsychiatric and sleep features
por: Bestwick, Jonathan P., et al.
Publicado: (2021)

Developing and assessing a new web-based tapping test for measuring distal movement in Parkinson’s disease: a Distal Finger Tapping test
por: Akram, Noreen, et al.
Publicado: (2022)

Insights on Genetic and Environmental Factors in Parkinson’s Disease from a Regional Swedish Case-Control Cohort
por: Brolin, Kajsa, et al.
Publicado: (2022)

PTPA variants and the risk for Parkinson’s disease in diverse ancestry populations
por: Ostrožovičová, Miriam, et al.
Publicado: (2023)

Domotics, Smart Homes, and Parkinson’s Disease
por: Simonet, Cristina, et al.
Publicado: (2021)

Improving estimation of Parkinson’s disease risk—the enhanced PREDICT-PD algorithm
por: Bestwick, Jonathan P., et al.
Publicado: (2021)

Association of polygenic risk score with response to deep brain stimulation in Parkinson’s disease
por: Yoon, Esther, et al.
Publicado: (2023)

PREDICT-PD: Identifying risk of Parkinson's disease in the community: methods and baseline results
por: Noyce, Alastair J, et al.
Publicado: (2014)

Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
por: Storm, Catherine S., et al.
Publicado: (2021)

The prodromes of Parkinson's disease
por: Rees, Richard Nathaniel, et al.
Publicado: (2018)

The Association Between Type 2 Diabetes Mellitus and Parkinson’s Disease
por: Cheong, Julia L.Y., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6tbc4qv2t0ba8n78dtsqddrs68